News from Indian authorities is that they have banned TikTok video service and another 58 Chinese applications. A statement about this is published on the website of the state PIB (Press Information Bureau, Bureau of Press and Information) of India.

 Blocked applications "are detrimental to the sovereignty and integrity of India, the protection of India, state security and public order," the statement said. The list of prohibited services was also posted on the agency’s website; TikTok leads it. In addition to the video platform, the list also included applications from the Chinese WeChat social network, the Weibo microblogging service, the UC browser, and others.

 The Cybercrime Center of India receives applications from citizens who are concerned about data security and privacy, the PIB said. “This step will protect the interests of Indian mobile and Internet users. This decision is a deliberate step to ensure the security and sovereignty of Indian cyberspace, ”the department concluded.

 TikTok has already responded to the lock. The head of the service division in India, Nikhil Gandhi, said that the application complies with the laws of the country and does not transfer data to other states. “The confidentiality and integrity of users are of utmost importance to us,” Gandhi said.

China seems to be hit by a new wave of coronavirus.  People in the northeast of the country can only leave the house for strictly necessary shopping.  This time it would be a form of the virus that has mutated.  The symptoms of the infection appear later and the disease is more difficult to cure.  Authorities imposed containment measures on the affected area.

Chinese officials have imposed quarantine restrictions on two cities in northeast China's Jilin province.  Jilin is part of a larger province in the Dongbei region - home to more than 100 million people.  Health authorities have raised the alert in the area, writes express.co.uk.

 About 40,000 residents of Jilin and Shulan were tested for coronavirus after officials were alerted to a possible new outbreak.

 In Jilin, authorities stopped all major transport links to and from neighboring cities until further notice.  In Shulan, all villages and residential complexes were closed after a similar outbreak of COVID-19 cases last week.

 Residents are allowed to leave their homes only for essential reasons, but not more than two hours, once every two days.  However, delivery services have been largely shut down, and anti-fever drugs are banned from pharmacies to prevent people from hiding their symptoms.

 Schools, public places and public transport have been closed.  Children can only play outside if they wear masks, and health care workers have returned to protective equipment, writes Bloomberg.

 Strict measures have raised concerns, as people believed the nation's worst epidemic was over.  The fear spread to nearby areas, although no cases have been officially reported in those places.

 The virus in the new outbreak has mutated

 The new virus that hit northeast China is behaving differently from the one in Wuhan, and researchers say it has undergone mutations.  Patients in China's new outbreaks appear to be carrying the virus for a longer period of time and need a longer recovery time.  In addition, the symptoms of the disease are felt more than two weeks after infection, say Chinese specialists, which makes it difficult to detect new cases. 

 However, it seems that patients rarely have a fever, and the virus affects only the lungs, not the other organs as is the case with the form discovered in Wuhan.  Moreover, it is believed that the new form of coronavirus is actually exported from abroad, the analysis of the strain of the new form of the virus resembling that of Russia.

China may be able to launch a vaccine against SARS-Cov-2 by the end of the year, a Chinese government agency announced on social media on Saturday.

The vaccine - developed by the Beijing Institute of Biological Products and the Institute of Virology - was administered to more than 2,000 people in phase 2 clinical trials, the Public Asset Management and Supervision Commission (SASAC) said.

 According to a message dated May 29, broadcast on the Chinese social network WeChat, the vaccine could be marketed as early as the end of this year or at the beginning of 2021.

 The two institutes that developed the vaccine have links to the Sinopharm pharmaceutical group, which in turn is controlled by SASAC.

 According to SASAC, the Beijing Institute of Biological Products is able to produce 100-120 million doses per year.

 Five vaccines are currently being tested on humans in China.